Complix's Grant

Complix raised a round of funding on December 21, 2010. Investors include IWT.

Complix is a biopharmaceutical company developing a pipeline of transformative protein therapeutics, called Alphabodies, that mainly focus on oncology and autoimmune diseases. Alphabodies are a class …

Articles about Complix's Grant: